Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents.

The oncologist(2023)

引用 0|浏览23
暂无评分
摘要
Higher BTS is associated with worse survival outcomes among patients receiving biomarker-matched, but not biomarker-unmatched TT.
更多
查看译文
关键词
baseline tumor size, tumor burden, targeted therapy, biomarker, phase I trials, solid tumor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要